We are live on ! Find out more
SOCM

SR One Capital Management Portfolio holdings

AUM $915M
1-Year Est. Return 209.71%
This Fund
S&P 500
This Quarter Est. Return
+18.03%
1 Year Est. Return
+209.71%
3 Year Est. Return
+484.66%
5 Year Est. Return
10 Year Est. Return
AUM
$177M
AUM Growth
Cap. Flow
+$160M
Cap. Flow %
90.4%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSGN icon
1
Design Therapeutics
DSGN
$915M
$120M 68.08%
+5,626,476
New +$96.6M
EFTR
2
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$56.5M 31.92%
+272,885
New +$63.3M

Similar funds

SR One Capital Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for SR One Capital Management, which disclosed 2 positions worth $177M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Design Therapeutics: 5,626,476 shares worth $120M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • SR One Capital Management's largest Q4 2021 buy was Design Therapeutics: 5,626,476 shares worth $120M.
  • SR One Capital Management's ten largest holdings make up 100% of its $177M portfolio in Q4 2021.
  • SR One Capital Management disclosed 2 positions in Q4 2021, its first 13F filing on record.

Based on SR One Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.